Vancouver, B.C., tissue ‘bioprinting’ company inks $75M deal with Novo Nordisk for diabetes, obesity Vancouver, B.C.-based biotech company Aspect Biosystems inked a partnership worth potentially more than $2.6 billion with Danish biopharma giant Novo… Read More
Tech Moves: Convoy names general counsel; startup founders land new gigs after shutdowns — Freight marketplace Convoy announced John Morrow as its new general counsel, effective Nov. 1. A Seattle tech vet, Morrow… Read More
Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools More than 100 million people in the U.S. have diabetes or pre-diabetes, making the disease one of the most common —… Read More
Drug maker Novo Nordisk confirms new obesity R&D center in Seattle Danish drug maker Novo Nordisk announced plans today to open a new obesity research unit in Seattle, a move that… Read More
Big news for biotech: Novo Nordisk considering Seattle for new obesity R&D center Seattle has been struck with some tough setbacks in the biotech community in the past few months, including the recent… Read More
